title: The role of the dorsolateral funiculi in the pain relieving effect of spinal cord stimulation: a study in a rat model of neuropathic pain.
abstract: Activation of the dorsal columns is relayed to supraspinal centers, involved in pain modulation, probably via the descending fibers in the dorsolateral funiculi (DLF). The present study examines the role of the DLF in the attenuation of pain-related signs by spinal cord stimulation (SCS). Several groups of rats were subjected to nerve injury and to chronic bilateral DLF lesions at C5-7 level. In each animal, two sets of miniature electrodes were implanted, a caudal system placed in the dorsal epidural space at low thoracic level and another implanted over the dorsal column nuclei, rostral to the lesions. Stimulation (50 Hz, 0.2 ms; 70 % of motor threshold) was applied for 5 min via either of the electrodes. Behavioral tests were used to assess the effects of SCS on the nerve injury-induced mechanical and cold hypersensitivity and heat hyperalgesia. Prior to application of SCS, antagonists to either of GABAA or B, 5-HT1 or 1-2 or α/β-adrenergic receptors were injected i.p. Both stimulations produced comparable decreases (80-90 % of the control) of neuropathic manifestations in rats with intact spinal cords. DLF lesions attenuated the effects of both types of stimulation by about 50 %. Pretreatment with receptor antagonists differentially counteracted the effects of rostral and caudal stimulation; the inhibition with rostral stimulation generally being more prominently influenced. These results provide further support to the notion of important involvement of brainstem pain modulating centers in the effects of SCS. A major component of the inhibitory spinal-supraspinal-spinal loop is mediated by fibers running in the DLF.
authors.affiliation: Department of Anatomy, Cell Biology and Physiology, American University of Beirut, Riad El Solh Beirut, Beirut, 1107-2020, Lebanon, nesaade@aub.edu.lb.
authors.forename: N E
authors.initials: NE
authors.lastname: Saadé
authors.forename: J
authors.initials: J
authors.lastname: Barchini
authors.forename: S
authors.initials: S
authors.lastname: Tchachaghian
authors.forename: F
authors.initials: F
authors.lastname: Chamaa
authors.forename: S J
authors.initials: SJ
authors.lastname: Jabbur
authors.forename: Z
authors.initials: Z
authors.lastname: Song
authors.forename: B A
authors.initials: BA
authors.lastname: Meyerson
authors.forename: B
authors.initials: B
authors.lastname: Linderoth
mesh_terms: D018674:Adrenergic Antagonists / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D004195:Disease Models, Animal; D018492:Dopamine Antagonists / Q000494:pharmacology; D018756:GABA Antagonists / Q000494:pharmacology; D006930:Hyperalgesia / Q000188:drug therapy; D009437:Neuralgia / Q000628:therapy*; D017288:Pain Threshold / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012702:Serotonin Antagonists / Q000494:pharmacology; D062187:Spinal Cord Stimulation / Q000379:methods*; D013126:Spinal Nerve Roots / Q000502:physiology*; D013997:Time Factors; D014110:Touch
chemical_list: D018674:Adrenergic Antagonists; D018492:Dopamine Antagonists; D018756:GABA Antagonists; D012702:Serotonin Antagonists